InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: HALF FULL GLASS post# 27279

Friday, 09/17/2010 10:23:01 AM

Friday, September 17, 2010 10:23:01 AM

Post# of 30387
My My, Half, what an incredibly juvenile tale. You think Moro has something secret that he isn't telling anyone? If you haven't noticed Half, Moro has been writing papers or presenting his work on RECAF at meeting for years and years yet apparently no one pays little attention.

Moro has been working with RECAF for about 26 years. Does anyone want to admit that their life's work has not met with success?

"There are many in this world that have never even heard of Recaf yet that are waiting for Recaf to be available."

OK Half, why aren't Vets buying RECAF like hotcakes?

RECAF for diagnostics is just technology that has not been accepted. If you listen to Moro, he makes the product sound fantastic. Look at Abbott. They licensed RECAF based on a small study in November 2004 that indicated 94% sensitivity and 100% specificity. Well, they licensed it for evaluation and found it wasn't even close to those numbers. Look at the contrasting data published in May 2006. Also look at the disclaimers for Dog RECAF to keep from being sued. There Moro discloses that at 99% specificity, the sensitivity can be as low as 50% to 65%. Now, those numbers I would believe and NOT the ones published in 2004 for Abbott.

So Half, the problem for investors in this stock is relying upon what Moro optimistically states. I agree that I had the same problem. I wanted to believe what he said.

GoldSeekerâ„¢

I have never shorted nor intend to have any financial interest in BOCX. I am not connected with anyone who trades, shorts or has financial interests in BOCX. I only post facts and my opinions. I do not post on IHUB with different aliases.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.